Ironbridge Capital
Ironbridge’s EnviroWaste could fetch healthy price
Ironbridge Capital is mulling the sale of its waste management company, EnviroWaste. The New Zealand-based firm is expected to sell for a healthy price as its Australian counterpart Thiess was bought for A$218 million ($225 million) earlier this month.
Ironbridge targets $1b for Fund III, invests $95m in dental business
Australian private equity house Ironbridge Capital has said it will target up to A$1 billion ($1 billion) for its third fund, for which it will begin fundraising in the second half of this year.
Ironbridge mulls IES SBO
Ironbridge Capital is reportedly among the private equity suitors looking to participate in the secondary buyout of CHAMP Private Equity’s International Energy Services (IES).
MediaWorks is latest Oz debt-to-equity target
The phenomenon is known as “loan to own.” Investors buy up companies’ debt on the secondary market and negotiate with the boards to secure what are in effect controlling positions.
TPG acquires 20% of MediaWorks' senior debt for $54m
TPG has acquired NZ$70 million ($54.1 million) worth of debt in New Zealand-based MediaWorks from lender Commonwealth Bank of Australia (CBA), accounting for approximately 20% of the company’s full debt load.
Australian lender sells debt in New Zealand media owner at a discount
A lender of Ironbridge Capital-owned MediaWorks, the New Zealand-based owner of TV and radio channels, is selling its NZ$70 million ($54.1 million) of senior debt in the asset for NZ$0.50 on the dollar.
Archer, Ironbridge achieve iNova exit
It may have taken longer than expected, but Archer Capital and Ironbridge Capital have finally exited Australian portfolio company iNova Pharmaceuticals to a Canadian trade buyer two years after launching an auction for the company. A healthy return on...
Archer, Ironbridge exit iNova Pharmaceuticals for $690m
Archer Capital and Ironbridge Capital have exited iNova Pharmaceuticals to Canada’s Valeant Pharmaceuticals in a deal worth up to A$700 million ($690 million). Valeant will pay A$625 million up front plus a further A$75 million based on the success...
Archer, Ironbridge consider iNova Pharmaceuticals sale
Archer Capital and Ironbridge are looking to sell iNova Pharmaceuticals for A$700-850 million ($714-878 million). The private equity firms have appointed Greenhill Caliburn to advise on the sale process and would like to have a deal in place by the end...
Bain buys MYOB as markets sink Sage bid
Recent turbulence in the global markets did private equity a favor last week as Bain Capital emerged as the unlikely victor in the auction for Australian accounting software firm MYOB. Bain and KKR had for several weeks been regarded as the frontrunners...
Archer’s fifth fund could reach $1.5b
Archer Capital’s much talked-of fifth fund could reach A$1.4 billion ($1.5 billion), with Future Fund expected to sign up as an investor, The Australian reported. The fundraising target was previously said to be A$ 1.2 billion ($1.27 billion).
Ironbridges exits oil rig company
Ironbridge has sold investee company Easternwell to engineering and maintenance services provider Transfield for A$575 million ($567 million). Sydney-based Transfield will pay A$540 million ($532 million) in cash and A$35 million ($34.5 million) in shares...
Australian private equity: Behind the numbers
Lower numbers mask resurgence
Crescent sells National Hearing Care to international buyer
Crescent Capital Partners and Macquarie Group have sold local hearing healthcare business National Hearing Care Group (NHC) to Italian hearing aid retailer Amplifon SA, the leading global player in the sector, for A$460 million ($441 million).
Archer, Ironbridge may join WSN Environmental auction
Australian private equity firms Archer Capital and Ironbridge Capital may participate in the upcoming auction of WSN Environmental Solutions, the state-owned company providing recycling and environmental services in the Greater Sydney area.
Julian Knights of Ironbridge Capital
Managing Director of Ironbridge Capital Management Julian Knights tells AVCJ that Australian private equity firms' focus on "unloved" assets is what makes the industry different from private equity investing in the US and the UK.
All smiles in Sydney as ANZ upbeat
AVCJ Forum ANZ highlights market strengths, local skills
Buyouts still viable in Asia Pacific: ANZ Forum
GPs, LP and other market players at the AVCJ Private Equity & Venture Forum \ ANZ 2010 confirmed that they feel buyouts are still viable deals in Asia Pacific, as long as targets are exceptionally strong.
CalPERS places spotlight on placement
One not strictly Asia Pacific development that emerged lately – but one that certainly has implications for GPs here – is the latest wrinkle in the ongoing controversy over the relationship between California Public Employees' Retirement System (CalPERS)...